Ravi Jandhyala
-
- Botulinum Toxin and Related Neurological Disorders 5
-
- Pharmaceutical industry and healthcare 5
-
- Facial Rejuvenation and Surgery Techniques 3
-
- Health Systems, Economic Evaluations, Quality of Life 11
- Pharmaceutical Economics and Policy 7
-
- Influenza Virus Research Studies 3
-
- Lipid metabolism and disorders 3
-
- Animal Disease Management and Epidemiology 3
- Co-authors
- Shweta BhagatRichard A. JohnstonCatherine MooreEmanuele MontomoliRaúl Ortíz de LejarazuSolomon ChristopherHemant SharmaShaishav Bhagat
- Cited by
- NephrologyNeurologyFamily Practice
- Journals
- The American Journal of Cardiology (1 paper)Vaccine (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- United KingdomSpainUnited States
In The Last Decade
Ravi Jandhyala
35 papers receiving 395 citations
Peers
Comparison fields: 5 of 88
- Nephrology 30
- Neurology 61
- Family Practice 8
- Pharmacology 31
- Dermatology 25
Countries citing papers authored by Ravi Jandhyala
This map shows the geographic impact of Ravi Jandhyala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Jandhyala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Jandhyala more than expected).
Fields of papers citing papers by Ravi Jandhyala
This network shows the impact of papers produced by Ravi Jandhyala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Jandhyala. The network helps show where Ravi Jandhyala may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ravi Jandhyala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 7 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 27 | |
| 13 | 2020 | 32 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 3 | |
| 16 | Improving consent procedures and evaluation of treatment success in cosmetic use of incobotulinumtoxinA: an assessment of the treat-to-goal approach. | 2013 | 11 |
| 17 | 2012 | 4 | |
| 18 | 2007 | 0 | |
| 19 | 2007 | 16 | |
| 20 | 2007 | 39 |
About Ravi Jandhyala
Ravi Jandhyala is a scholar working on Pharmacology, Neurology and Family Practice, having authored 39 papers that have together received 404 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Pharmaceutical Economics and Policy (7 papers), Botulinum Toxin and Related Neurological Disorders (5 papers), Pharmaceutical industry and healthcare (5 papers), Influenza Virus Research Studies (3 papers), Facial Rejuvenation and Surgery Techniques (3 papers), Lipid metabolism and disorders (3 papers) and Animal Disease Management and Epidemiology (3 papers). The work is most often cited by research in Nephrology (30 citations), Neurology (61 citations) and Family Practice (8 citations). Ravi Jandhyala has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Shweta Bhagat, Richard A. Johnston, Catherine Moore, Emanuele Montomoli, Raúl Ortíz de Lejarazu, Solomon Christopher, Hemant Sharma, Shaishav Bhagat, Anne Mosnier and Mahesh Chand Bansal. Their work appears in journals such as The American Journal of Cardiology, Vaccine and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.